| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.058 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |